KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $89.0 million.

  • Quest Diagnostics' Dividends Paid - Common rose 595.24% to $89.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $347.0 million, marking a year-over-year increase of 611.62%. This contributed to the annual value of $331.0 million for FY2024, which is 541.4% up from last year.
  • Per Quest Diagnostics' latest filing, its Dividends Paid - Common stood at $89.0 million for Q3 2025, which was up 595.24% from $90.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Dividends Paid - Common registered a high of $90.0 million during Q2 2025, and its lowest value of $74.0 million during Q1 2022.
  • In the last 5 years, Quest Diagnostics' Dividends Paid - Common had a median value of $80.0 million in 2023 and averaged $80.1 million.
  • In the last 5 years, Quest Diagnostics' Dividends Paid - Common skyrocketed by 800.0% in 2021 and then plummeted by 370.37% in 2022.
  • Over the past 5 years, Quest Diagnostics' Dividends Paid - Common (Quarter) stood at $77.0 million in 2021, then dropped by 2.6% to $75.0 million in 2022, then rose by 6.67% to $80.0 million in 2023, then rose by 5.0% to $84.0 million in 2024, then increased by 5.95% to $89.0 million in 2025.
  • Its Dividends Paid - Common was $89.0 million in Q3 2025, compared to $90.0 million in Q2 2025 and $84.0 million in Q1 2025.